Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Minority Interest: 2009-2016

Historic Minority Interest for UNITED THERAPEUTICS (UTHR) over the last 6 years, with Dec 2016 value amounting to $10.9 million.

  • UNITED THERAPEUTICS's Minority Interest changed negligibly% to $10.9 million in Q4 2016 from the same period last year, while for Dec 2016 it was $10.9 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $10.9 million for FY2016, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q4 2016, UNITED THERAPEUTICS's Minority Interest is $10.9 million, which was down 0.00% from $10.9 million recorded in Q4 2015.
  • In the past 5 years, UNITED THERAPEUTICS's Minority Interest registered a high of $10.9 million during Q4 2015, and its lowest value of $10.9 million during Q1 2012.
  • For the 3-year period, UNITED THERAPEUTICS's Minority Interest averaged around $10.9 million, with its median value being $10.9 million (2015).
  • Data for UNITED THERAPEUTICS's Minority Interest shows a peak YoY grew of 0.17% (in 2015) over the last 5 years.
  • Over the past 5 years, UNITED THERAPEUTICS's Minority Interest (Quarterly) stood at $10.9 million in 2012, then remained steady at $10.9 million in 2013, then remained steady at $10.9 million in 2014, then increased by 0.17% to $10.9 million in 2015, then remained steady at $10.9 million in 2016.
  • Its last three reported values are $10.9 million in Q4 2016, $10.9 million for Q4 2015, and $10.9 million during Q3 2015.